Mylan completes acquisition two dermatological products from Valeant

Mylan completes acquisition of two dermatological products from Valeant

2:41 AM, 7th February 2012
Mylan completes acquisition of two dermatological products from Valeant
Heather Bresch, Chief Executive Officer, Mylan.

PITTSBURGH, US: Mylan Inc announced that it has successfully completed the acquisition of two dermatological products from Valeant Pharmaceuticals. Mylan has acquired the abbreviated new drug application for clindamycin phosphate/ benzoyl peroxide gel, which is the generic version of Valeant’s BenzaClin. Mylan previously had manufactured and marketed the generic version of this product through a licensing agreement with Valeant. Mylan also has acquired a license to manufacture and market Fluorouracil 5 per cent USP cream as the exclusive authorized generic to Valeant’s Efudex.

“The acquisition of these two products reflects Mylan’s continued strategy of creating value through increasing our position in key therapeutic areas and dosage forms, such as dermatological topicals. Further, it allows us to expand our portfolio of difficult-to-manufacture or limited-competition products. We will continue to build on our existing portfolio and capabilities through opportunities such as these,” said Heather Bresch, Chief Executive Officer, Mylan.

© WOC News

0 Comments

Login

Your Comments (Up to 2000 characters)
Please respect our community and the integrity of its participants. WOC reserves the right to moderate and approve your comment.

Related News


Huntsman appoints Jon Huntsman Jr. as board member

THE WOODLANDS, US: Huntsman Corporation announced the appointment of Jon Huntsman Jr. as a new director to its board of directors effective from 1 Feb ...

Read more
BP changes board members

LONDON, UK: The board of BP announced that Professor Dame Ann Dowling will join the board as a Non- Executive Director with immediate effect. It was f ...

Read more
ExxonMobil grants MazeFlo sand control screen license to Weatherford

HOUSTON, US: ExxonMobil Upstream Research Company announced that it has awarded Weatherford International Ltd the first global license for the compa ...

Read more
Sumitomo Chemical to build a new plant in Singapore for S-SBR production

TOKYO, JAPAN: Sumitomo Chemical announced that it will construct a new solution styrenebutadiene rubber (S-SBR) manufacturing plant in Singapore by ...

Read more
Air Liquide to invest €40 million in ASU in South Africa

PARIS, FRANCE: Air Liquide said that it will invest €40 million in a new air separation unit (ASU) in South Africa. Air Liquide has signed a majo ...

Read more
Solvay commissions PEM fuel cell at SolVin plant

BRUSSELS, BELGIUM: Solvay announced that it has successfully commissioned its 1 megawatt (MW) industrial demonstration fuel cell at the SolVin plant i ...

Read more